1Australian Centre for Health Law Research, Queensland University of Technology, Brisbane, Australia.
2Health Program, St. Francis Xavier University, Antigonish, Canada.
OMICS. 2019 Aug;23(8):406-415. doi: 10.1089/omi.2019.0053.
How do postgenomic innovations emerge and become legitimate? Proteomics, a frequently utilized postgenomic technology, provides a valuable case study of the sociotechnical strategies used by an emergent scientific field to establish its legitimacy and assert political power. Chief among these strategies is standard making, an inherently political process that requires examination through a critical social science lens. We report in this study an original case study from interviews with proteomics scientists and observations at conferences of the Human Proteome Organization and Australasian Proteomics Society over a 5-year period (2011-2015). The study contributes new knowledge on how an emerging postgenomic science uses standard-setting practices to politically legitimize a hitherto contested technology. Drawing on legitimacy theory, we show how proteomics scientists and organizations used standards as strategic tools to establish the legitimacy of this postgenomic field and affirm that proteomics can generate verifiable and reproducible results, thereby establishing it as a legitimate scientific field. Notably, legitimacy can be leveraged, at the same time, to maximize political power vis-à-vis other fields of science and as such embodies power relationships. These data collectively inform the broader context, in which postgenomic innovations emerge and legitimize, both technically and politically, through standards making. These findings have relevance for the design of next generation technology policies by demonstrating that standards are not "just" standards or neutral constructs but also tools to leverage political power of and by science and innovation actors, as shown in this case study of the emerging early phase of proteomics from 2011 to 2015.
后基因组创新是如何出现并合法化的?蛋白质组学是一种常用的后基因组技术,为新兴科学领域采用的建立合法性和主张政治权力的社会技术策略提供了一个有价值的案例研究。这些策略中最重要的是标准制定,这是一个内在的政治过程,需要通过批判性社会科学的视角进行检验。我们在这项研究中报告了一个原始的案例研究,该研究通过对蛋白质组学科学家的访谈以及在人类蛋白质组组织和澳大拉西亚蛋白质组学会会议上进行的为期 5 年(2011-2015 年)的观察得出。该研究提供了新知识,说明新兴的后基因组科学如何利用标准制定实践来使一项迄今有争议的技术在政治上合法化。借鉴合法性理论,我们展示了蛋白质组学科学家和组织如何将标准作为战略工具,确立这个后基因组领域的合法性,并确认蛋白质组学可以产生可验证和可重复的结果,从而将其确立为一个合法的科学领域。值得注意的是,合法性可以同时被利用,以最大限度地提高相对于其他科学领域的政治权力,因此体现了权力关系。这些数据共同为更广泛的背景提供了信息,在后基因组创新通过标准制定在技术和政治上出现并合法化。这些发现对于下一代技术政策的设计具有相关性,因为它们表明标准不仅仅是“标准”或中立的结构,而且还是科学和创新参与者利用政治权力的工具,正如 2011 年至 2015 年期间蛋白质组学新兴早期阶段的案例研究所示。